During the past decade, Stanford Neuroscience Health Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanford Neuroscience Health Center" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Theravance Biopharma" with 2 trials sponsored, "Addex Pharma S.A." with 1 trials sponsored and "Engage Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

According to Clinical.Site data, the most researched conditions in "Stanford Neuroscience Health Center" are "Multiple Sclerosis" (2 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (2 trials), "Alzheimer Disease" (1 trials), "Cluster Headache, Episodic" (1 trials) and "Duchenne Muscular Dystrophy" (1 trials). Many other conditions were trialed in "Stanford Neuroscience Health Center" in a lesser frequency.

Most popular intervention types in "Stanford Neuroscience Health Center" are "Drug" (14 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Antihistamine" (2 trials), "Methylprednisolone" (2 trials), "Ocrelizumab" (2 trials) and "Placebos" (2 trials). Other intervention names were less common.

The vast majority of trials in "Stanford Neuroscience Health Center" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Stanford Neuroscience Health Center". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Stanford Neuroscience Health Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Stanford Neuroscience Health Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".